Hypoactive sexual desire disorder

被引:0
|
作者
Przybylski, Marcin
Spaczynski, Marek
机构
关键词
sexual dysfunction; Hypoactive Sexual Desire Disorder; female sexuality; UNITED-STATES; DYSFUNCTION; WOMEN; PREVALENCE; THERAPY; DEFINITIONS; SCREENER; BEHAVIOR;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Sexual dysfunctions in women is a topic that has only just started to appear in scientific publications. Relatively little is known about the extent of the problem, but some reports suggest that sexual dysfunctions are highly prevalent, affecting 20% to even over 40% of all women. Most authors agree that female sexual dysfunctions are age-related. Epidemiological data confirms that fact and shows that one third of women demonstrate lack of interest in sex and nearly one fourth do not achieve orgasm. Approximately 20% of women report difficulties with vaginal lubrication and for 20% sex is not enjoyable. For many of them such problems influence the relationships with their partner in a negative way and are the reason of personal failures and. It should be emphasized that Hypoactive Sexual Desire Disorder is the most prevalent sexual dysfunction in all female age groups. Until 50 years ago, sexual dysfunction was not regarded as a serious medical problem which is directly responsible for scarce or limited clinical data available on the topic nowadays. The mechanisms underlying Hypoactive Sexual Desire Disorder remain elusive and, as a consequence, in most cases there is still no effective treatment. In recent months, reports have been published suggesting that the situation may change soon, The introduction of new diagnostic tools and data from completed clinical trial phases may prove a real breakthrough in the diagnostics and treatment of the hypoactive sexual desire disorder.
引用
收藏
页码:518 / 522
页数:5
相关论文
共 50 条
  • [11] THE PATHOPHYSIOLOGY OF HYPOACTIVE SEXUAL DESIRE DISORDER IN WOMEN
    Clayton, Anita H.
    [J]. GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2010, 32 (06): : 359 - 365
  • [12] Definition of HSDD (Hypoactive Sexual Desire Disorder)
    Naumann, G.
    Skala, C.
    Albrich, S.
    Koelbl, H.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2010, 70 (09) : 701 - 706
  • [13] Clinical management of hypoactive sexual desire disorder
    Kingsberg, Sheryl
    Faubion, Stephanie
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (02): : 217 - 219
  • [14] New Approach on Hypoactive Sexual Desire Disorder
    Vladareanu, Radu
    Petca, Aida
    [J]. GINECO RO, 2010, 6 (04): : 256 - 260
  • [15] Diagnosis and Treatment of Hypoactive Sexual Desire Disorder
    Amato, Paula
    Buster, John E.
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2009, 52 (04): : 666 - 674
  • [16] The pathophysiology of hypoactive sexual desire disorder in women
    Clayton, Anita H.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 110 (01) : 7 - 11
  • [17] Bremelanotide (Vyleesi) for Hypoactive Sexual Desire Disorder
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1577): : 114 - 116
  • [18] Hypoactive sexual desire disorder in postmenopausal women
    Nappi, Rosselia E.
    Wawra, Kathrin
    Schmitt, Sonja
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2006, 22 (06) : 318 - 323
  • [19] IS THERE A ROLE FOR DRUGS IN HYPOACTIVE SEXUAL DESIRE DISORDER?
    Giraldi, Annamaria
    [J]. JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 85 - 86
  • [20] Evaluation and Management of Hypoactive Sexual Desire Disorder
    Clayton, Anita H.
    Kingsberg, Sheryl A.
    Goldstein, Irwin
    [J]. SEXUAL MEDICINE, 2018, 6 (02) : 59 - 74